UK Rejects 28-Day Swim Ban After Flea Treatment, Delays Sales Decision

The UK government kept the four-day bathing and swimming rule for flea and tick treatments and has not decided whether sales should require professional advice.

A dog joyfully swimming in a calm river with sunlight reflections in Durbuy, Belgium.
Photo: Maurice Engelen / Pexels

The UK government has turned down a proposal to extend the period after a flea and tick treatment during which a pet should not bathe or swim from four days to 28 days, according to GlobalPETS. It has also not decided whether these products should be sold only through channels that include professional advice.

The decisions are part of the government’s reply to eight recommendations from the House of Lords Environment and Climate Change Committee, published on Aug. 5. The recommendations concern pet parasite medications, particularly those containing fipronil and imidacloprid, two widely used ectoparasiticides (products that kill fleas and ticks on the animal).

Why the bathing rule stays at four days

The committee also wanted bathing restrictions printed clearly on packaging instead of being given only through QR codes. The government said the evidence on how much bathing and swimming releases these chemicals into the environment is not strong enough to justify a longer restriction. It said any label change should rest on a sound environmental risk assessment framework with validated exposure models. For now it considers existing guidance, backed by education and responsible-use initiatives, the most proportionate approach.

Who can sell flea and tick products is still open

One recommendation would end general sale of these medications and require, at a minimum, sale through Non-Food Animal Veterinarian, Pharmacist, Suitably Qualified Person (NFA-VPS) channels, where an authorized professional gives advice. It argues that treatment should depend on each animal’s needs, lifestyle, location and risk factors, and it calls for tighter control of online sales.

The government said it recognizes concerns about routine use but that any change must balance environmental protection with animal welfare, public health, access to treatment, affordability and consumer choice. The Veterinary Medicines Directorate (VMD) is reviewing the distribution categories for products with fipronil or imidacloprid, based on its April 2026 call for evidence. A summary of responses was expected in late October 2026. Deciding on all products before that review ends would be premature, the government said.

What the government accepted

It agreed with three of the five recommendations GlobalPETS identified as having commercial implications. One asks the VMD to publish anonymized data on sales and use of these products. The VMD already receives sales data for safety monitoring and is modernizing its digital systems, which could support publishing aggregated figures where legally possible. The government added that sales figures alone cannot show how products are used, so other data is needed.

It also agreed that the VMD should introduce Phase II environmental risk assessments. Under international guidelines, assessments for companion animal parasiticides currently stop at Phase I, based on the old assumption that individual pet treatments cause negligible exposure. Evidence of contamination through wastewater and dogs swimming in surface waters has challenged that view. No agreed Phase II method exists yet, and the VMD has commissioned research on exposure models. The UK may consider introducing Phase II assessments nationally if international agreement is delayed.

The government supports better training and advice for people who supply these products, so they can guide owners toward treatment based on individual risk. No agreed framework for risk-based use exists, and the VMD has commissioned research to set out its principles and risk factors.

What this means for pet owners

Nothing changes on shelves or labels for now. The four-day rule remains, and products stay in their current supply categories while the VMD review continues. Owners with questions about which treatment suits their animal can ask their veterinarian.

Other recommendations

The government supports building the evidence on contamination in waterways, soils and sewage sludge, and says the Pharmaceuticals in the Environment group is already working on it. It agreed to review governance between the VMD, industry and the international body VICH. After looking at the VMD’s processes, it said safeguards are in place and found no evidence of regulatory capture. It partly agreed to fund research on parasite prevalence, zoonotic risks and health impacts, and said the need for more research will be assessed as evidence develops.

Source: GlobalPETS

Prepared by PetsTips with AI-assisted drafting and automated fact checks — see our editorial policy. Spotted an error? Tell us.